Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT07567690
Real-world Immunogenicity of Anti-IL5/5a Antibody
Sponsor: Samsung Medical Center
View on ClinicalTrials.gov
Summary
This study aims to evaluate the immunogenicity of the drug by measuring anti-drug antibody (ADA) formation and titers. The presence of ADAs will be assesses to determine their potential impact on the drug's efficacy and safety.
Official title: A Prospective Observational Study of Biologic Treatment and Outcomes in Patients With Severe Asthma (BREATH)
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2025-08-19
Completion Date
2026-12-31
Last Updated
2026-05-05
Healthy Volunteers
No
Conditions
Locations (1)
Samsung Medical Center
Seoul, South Korea